Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend

Scientific Session

Osteoarthritis (OA) and Related Disorders

Session: GLP1 Agonists in Rheumatic Disease and Osteoarthritis: Should We Give Them to Everyone?

GLP1 Agonists in Osteoarthritis: Preclinical Studies

Monday, October 27, 2025
11:00 AM – 11:30 AM Central Time

    Speaker(s)

  • FB

    Francis Berenbaum, MD, PhD

    Sorbonne University - Saint-Antoine hospital
    Paris, France

    Disclosure(s): 4Moving Biotech: Intellectual Property/Patents (Ongoing), Ownership Interest (Ongoing); 4P Pharma: Advisor or Review Panel Member (Ongoing); AstraZeneca: Advisor or Review Panel Member (Ongoing); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing); Grunenthal: Advisor or Review Panel Member (Ongoing); Healthnix: Advisor or Review Panel Member (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing); Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Torque: Advisor or Review Panel Member (Ongoing); Zoetis: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)